(Q44907869)

7 December 2017

Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy (English)

1 reference

7 December 2017

1 reference

Joshua S Benner

1

1 reference

7 December 2017

Jonothan C Tierce

2

1 reference

7 December 2017

Christie M Ballantyne

3

1 reference

7 December 2017

Cheryl Prasad

4

1 reference

7 December 2017

Michael F Bullano

5

1 reference

7 December 2017

Vincent J Willey

6

1 reference

7 December 2017

John Erbey

7

1 reference

7 December 2017

David S Sugano

8

1 reference

7 December 2017

1 January 2004

1 reference

7 December 2017

1 reference

7 December 2017

22 Suppl 3

1 reference

7 December 2017

13-23

1 reference

https://scigraph.springernature.com/pub.10.2165/00019053-200422003-00003

7 December 2017

0 references

cites work

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00003

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00003

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00003

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00003

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00003

The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00003

Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00003

Enhancing drug compliance in lipid-lowering treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00003

The problem of compliance to cholesterol altering therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00003

Resource management in prevention of coronary heart disease: optimising prescription of lipid-lowering drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00003

A Telecommunications System for Monitoring and Counseling Patients With Hypertension Impact on Medication Adherence and Blood Pressure Control

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00003

Work-site treatment of hypertension by specially trained nurses. A controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00003

Improvement of medication compliance in uncontrolled hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00003

Optimizing treatment of dyslipidemia in patients with coronary artery disease in the managed-care environment (the Rocky Mountain Kaiser Permanente experience).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00003

A case-management system for coronary risk factor modification after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200422003-00003

Apparent discontinuation rates in patients prescribed lipid-lowering drugs.

21 January 2018

1 reference

12 December 2020

Effectiveness of antihyperlipidemic drug management in clinical practice

1 reference

12 December 2020

AACE medical guidelines for clinical practice for the diagnosis and treatment of dyslipidemia and prevention of atherogenesis.

1 reference

12 December 2020

Management of dyslipidemia in adults with diabetes

1 reference

12 December 2020

A randomized controlled trial of compliance improving strategies in Soweto hypertensives

1 reference

12 December 2020

Factors affecting patient compliance with antihyperlipidemic medications in an HMO population

1 reference

12 December 2020

Patient adherence: a 'risk factor' for cardiovascular disease

1 reference

12 December 2020

Persistence of use of lipid-lowering medications: a cross-national study

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Long-term persistence in use of statin therapy in elderly patients

1 reference

12 December 2020

Compliance and adverse event withdrawal: their impact on the West of Scotland Coronary Prevention Study

1 reference

12 December 2020

Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention

1 reference

12 December 2020

10.2165/00019053-200422003-00003

Identifiers

DOI

0 references

Dimensions Publication ID

0 references

1 reference